Federico Raccah

General Partner NRG| Business Angel & Advisor IAG| CEO M&F

📍 Rome, Latium, Italy🔄 Updated October 2026💼 7 investments📅 14 years investing🗓 Last invested Dec 2020
Operator-angel🌍 Italy
7
Total investments
4
Early stage
0
Mid stage
1
Late stage
14y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2020
Teraloop is developing a kinetic energy storage system through an innovative fusion of electromagnetic technologies, each already proven in its existing application. Electrical energy is converted to stored kinetic energy, then harvested as required.
Investor
Jun 2019
Kither Biotech is a biopharmaceutical company that develops novel therapies for the treatment of rare pulmonary diseases with an high unmet medical need. Our first two product candidates KIT2014 and KITCL27, focus on cystic fibrosis and idiopathic pulmonary fibrosis respectively.
Investor
May 2018
Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide. Alpha DaRT Breakthrough Cancer Treatment Alpha DaRT enables high-precision alpha radiation for all types of solid tumors. The treatment is delivered by inserting with Radium-224 impregnated seeds into the tumor. When the Radium decays, its short-lived daughters are released from the seed, disperse into the tumor and emit high-energy alpha particles which destroy the tumor. Since the alpha-emitting atoms hardly diffuse in healthy tissue, the Alpha DaRT mainly affects the tumor, sparing the healthy tissue around it. Alpha DaRT has several important advantages: • Highly potent and conformal • Proven efficacy for all solid tumors tested • Enhances systemic anti-tumor immune response • Effective regardless of tumor oxygen level • Short half-life – quick clinical outcome • No known negative systemic effects • Single-session treatment • Enables combination with other therapies or reapplication • Disposable applicators - does not require capital equipment or special shielding
Founder / Lead Investor
May 2017
Uno spazio polifunzionale dove fare impresa e generare circoli virtuosi per il successo di business innovativi appositamente selezionati. Un team dinamico, giovane ed appassionato composto da esperti di marketing, creativi, startupper, digital marketers ma anche manager di importanti aziende, advisor, investitori e specialisti in strategia d'impresa e lean management. "Marmellata"​ perché qui idee, persone e competenze si mescolano e si contaminano per crescere e generare valore e innovazione insieme. "Marmellata"​ perché ci vuole dedizione, passione e tante ore di "cottura"​ per prepararla. "Marmellata"​ perché per farla buona servono i migliori ingredienti.. e il prossimo potresti essere tu!
Founder/ Seed investor
Dec 2015
Vikey is an Italian innovative start-up in the hospitality business, that allows hosts to check-in their guests with a 24/7 concierge, directly from their smartphone. Our goal is to offer a faster and more efficient solution to hosts, in order to improve their business quality standards and, at the same time, offering their customers unique experiences. Vikey is present all over Italy and also in Spain, Portugal, Scotland, England and Dubai. To date Vikey has collected 1.6 million euros.
early stageHospitality
Advisor / Lead Investor
Mar 2012
Energy efficency & Financing Pandora Escoled nasce dalla joint venture tra il comparto private equity del gruppo immobiliare M&F e la divisione sviluppo della società di produzione lampade Pandoragreen Grazie ad una consolidata esperienza multidisciplinare sull’efficientamento energetico e sulla gestione/sviluppo immobiliare, la Pandora Escoled è in grado oggi di offrire una nuova soluzione green per i conti delle Imprese e della Pubblica Amministrazione. Intervenendo meramente sulla componente di costo legata al Lighting, Escoled si propone come bridge finanziario per la sostituzione e creazione di nuovi impianti di illuminazione più performanti, riducendo mediamente del 60% i costi di bolletta per le aziende Formazione, Innovazione e Specializzazione rappresentano il primo investimento della Escoled per garantire ai propri clienti un servizio a 360° che comprende le diverse fasi di: - Audit energetico: analisi e screening dei consumi, rendicontazione e verifica conformità di legge - Progettazione & sviluppo impianto: la società, mediante un team specializzato di ingegneri e tecnici, offre - Customizzazione del prodotto/offerta - Installazione - Misurazione energetica - Manutenzione La Pandora Escoled ha ideato un sistema per imprese e Pubblica Amministrazione che permette al conduttore di avere, senza alcun esborso, un nuovo impianto di illuminazione, un servizio gratuito di manutenzione e una percentuale del risparmio energetico prodotto dai dispositivi tecnologici installati. Multinazionali come Pirelli, Unilever, Fao nonché molte aziende sul territorio nazionale hanno già aderito al servizio contribuendo alla crescita della società e del nuovo modello di business delle Energy Service Companies
Experience · 10 entries
All (10)
Investments (5)
Founder (3)
2020
Investor
Dec 2020
Teraloop is developing a kinetic energy storage system through an innovative fusion of electromagnetic technologies, each already proven in its existing application. Electrical energy is converted to stored kinetic energy, then harvested as required.
2019
Investor
Jun 2019
Kither Biotech is a biopharmaceutical company that develops novel therapies for the treatment of rare pulmonary diseases with an high unmet medical need. Our first two product candidates KIT2014 and KITCL27, focus on cystic fibrosis and idiopathic pulmonary fibrosis respectively.
Partner & Advisor
Mar 2019
Lybra Tech is an Italian Big data company that has developed software for anlysis and revenue management for the hospitality industry. In May 2020, Lybra was acquired by The Zucchetti Group, a leading international technology company offering software, hardware and ITC services to many global sectors, including hospitality, education, transport & logistics, manufacturing, among others. To find out more, visit Lybra at www.lybra.tech
2018
Investor
May 2018
Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide. Alpha DaRT Breakthrough Cancer Treatment Alpha DaRT enables high-precision alpha radiation for all types of solid tumors. The treatment is delivered by inserting with Radium-224 impregnated seeds into the tumor. When the Radium decays, its short-lived daughters are released from the seed, disperse into the tumor and emit high-energy alpha particles which destroy the tumor. Since the alpha-emitting atoms hardly diffuse in healthy tissue, the Alpha DaRT mainly affects the tumor, sparing the healthy tissue around it. Alpha DaRT has several important advantages: • Highly potent and conformal • Proven efficacy for all solid tumors tested • Enhances systemic anti-tumor immune response • Effective regardless of tumor oxygen level • Short half-life – quick clinical outcome • No known negative systemic effects • Single-session treatment • Enables combination with other therapies or reapplication • Disposable applicators - does not require capital equipment or special shielding
General partner
Mar 2018
Nexta Renewable Gas è una società italiana, specializzata nella progettazione, costruzione e gestione di impianti di produzione di Biometano. Nasce dalla partnership tra Nexta Capital Partners (Investment banking boutique), M&F HOLDING e Anacot. La società ha come obiettivo avviare un percorso di economia circolare per le aziende, attraverso la transazione energetica, con un processo di recupero del rifiuto a fine vita. Nexta Renewable Gas realizza e gestisce sistemi di raccolta e impianti per la selezione, trattamento e trasformazione dei rifiuti in energia per dare vita a nuovi cicli produttivi e di consumo.
Show all 10 entries ↓
Investment activity
2012–2020 · 7 investments
201212015120171201822019120201
Recent (last 2 years)Earlier